Trial intelligence / Profile preview

Perioperative drug dosing and tissue pharmacokinetics in obese and non-obese surgical patients

2012-004383-22Phase 3Completed

Sponsor
Leipzig University
Start
Jan 2013
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of linezolid, meropenem, acetaminophen, Metamizole sodium, tigecycline and 2 more in surgical site infection (SSI) and postoperative pain (4 arms), sponsored by Leipzig University. Primary endpoint: Interstitial fluid antibiotic exposure. Started Jan 2013; status: completed.

02

Drugs

linezolidmeropenemacetaminophenMetamizole sodiumtigecycline
03

Conditions

surgical site infection (SSI)postoperative pain

Beyond the preview

Go deeper on 2012-004383-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004383-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call